Identifying patient populations at high risk for stroke

Neurology

Volumn 51, Issue 3 SUPPL., 1998, Pages

  Sacco, Ralph L ^a,b  

^a NEUROLOGICAL INSTITUTE   (United States)

^b Box 6 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; ARTICLE; CEREBROVASCULAR ACCIDENT; CIGARETTE SMOKING; COMORBIDITY; DIABETES MELLITUS; HEART ATRIUM FIBRILLATION; HIGH RISK POPULATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; PRIORITY JOURNAL; RECURRENCE RISK; RISK ASSESSMENT; RISK FACTOR; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 0031689642     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.51.3_suppl_3.s27     Document Type: Article

References (34)

1. American Heart Association. Heart and stroke facts: 1996 statistical supplement. Dallas, TX: The Association, 1995.
2. Gorelick PB. Stroke prevention: windows of opportunity and failed expectations? A discussion of modifiable cardiovascular risk factors and a prevention proposal. Neuroepidemiology 1997;16:163-173.
3. Anderson CS. Contribution of prevention to vascular cerebral disease management. J Hypertens 1996;14(suppl. 6):S25-28.
4. Sacco RL, Benjamin EJ, Broderick JP, et al. American Heart Association Prevention Conference, IV: prevention and rehabilitation of stroke. Risk factors. Stroke 1997;28:1507-1517.
5. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/ Northern Kentucky Stroke Study. Preliminary first-ever and total incidence rates of stroke among blacks. Stroke 1998;29: 415-421.
6. Sacco RL, Boden-Albala B, Gan R, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998;147:259-268.
7. Kiely DK, Wolf PA, Cupples LA, Beiser AS, Myers RH. Familial aggregation of stroke: the Framingham Study. Stroke 1993;24:1366-1371.
8. Strandgaard S. Hypertension and stroke. J Hypertens 1996; 14(suppl 3):S23-27.
9. MacMahon S, Rodgers A. Blood pressure, antihypertensive treatment and stroke risk. J Hypertens Suppl 1994;12:S5-14.
10. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265: 3255-3264.
11. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-988.
12. Atrial Fibrillation Investigators. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457.
13. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;342: 1255-1262.
14. Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 1996;348:633-638.
15. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989;298:789-794.
16. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: the Framingham Study. JAMA 1988;259:1025-1029.
17. Wannamethee SG, Shaper AG, Whincup PH, Walker M. Smoking cessation and the risk of stroke in middle-aged men. JAMA 1995;274:155-160.
18. Kawachi I, Colditz GA, Stampfer MJ, et al. Smoking cessation and decreased risk of stroke in women. JAMA 1993;269:232-236.
19. Furberg CD, Adams HP Jr, Applegate WB, et al. Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Circulation 1994;90:1679-1687.
20. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
21. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trials investigators. N Engl J Med 1996;335:1001-1009.
22. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality: an overview of randomized trials. JAMA 1997;278:313-321.
23. Camargo CA Jr. Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke 1989;20:1611-1626.
24. Sacco RL, Lin IF, Boden-Albala B, et al. Alcohol and the risk of ischemic stroke: verification of a J-shaped relationship from the Northern Manhattan Stroke Study [abstract]. Stroke 1997;28:250.
25. Asymptomatic Carotid Atherosclerosis Study Investigators. Clinical advisory: carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. Stroke 1994; 25:2523-2524.
26. Feinberg WM. Guidelines for the management of transient ischemic attacks. Heart Dis Stroke 1994;3:275-283.
27. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-1398.
28. Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR. Determinants of early recurrence of cerebral infarction: the Stroke Data Bank. Stroke 1989;20:983-989.
29. Wilterdink JL, Easton JD. Vascular event rates in patients with atherosclerotic cerebrovascular disease. Arch Neurol 1992;49:857-863.
30. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-634.
31. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke: the Framingham Study. Stroke 1982;13:290-295.
32. Broderick JP, Phillips SJ, O'Fallon WM, Frye RL, Whisnant JP. Relationship of cardiac disease to stroke occurrence, recurrence, and mortality. Stroke 1992;23:1250-1256.
33. Alter M, Sobel E, McCoy RL, et al. Stroke in the Lehigh Valley: risk factors for recurrent stroke. Neurology 1987;37: 503-507.
34. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50:208-216.